Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Positive-Controlled, Placebo-Controlled, 4-Period Crossover Study to Investigate the Electrocardiographic Effects of BMS-986165 in Healthy Subjects
Conditions
Interventions
BMS-986165
Moxifloxacin
+1 more
Locations
1
United States
PRA Health Sciences
Lenexa, Kansas, United States
Start Date
May 30, 2018
Primary Completion Date
September 4, 2018
Completion Date
September 4, 2018
Last Updated
January 27, 2020
NCT06647069
NCT06342713
NCT07310901
NCT07371468
NCT07401472
NCT06333483
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions